Risk factors for infection, predictors of severe disease and antibody response to COVID-19 in patients with rheumatic diseases in Portugal – a multicentre, nationwide study
Ana Rita Cruz-Machado, View ORCID ProfileSofia C Barreira, Matilde Bandeira, Marc Veldhoen, Andreia Gomes, Marta Serrano, Catarina Duarte, Maria Rato, Bruno Miguel Fernandes, Salomé Garcia, Filipe Pinheiro, Miguel Bernardes, Nathalie Madeira, Cláudia Miguel, Rita Torres, Ana Bento Silva, Jorge Pestana, Diogo Almeida, Carolina Mazeda, Filipe Cunha Santos, Patrícia Pinto, Marlene Sousa, Hugo Parente, Graça Sequeira, Maria José Santos, João Eurico Fonseca, View ORCID ProfileVasco C Romão
doi: https://doi.org/10.1101/2021.10.01.21264428
Ana Rita Cruz-Machado
1Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Center and European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ERN-ReCONNET), Lisbon, Portugal. Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
Sofia C Barreira
1Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Center and European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ERN-ReCONNET), Lisbon, Portugal. Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
Matilde Bandeira
1Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Center and European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ERN-ReCONNET), Lisbon, Portugal. Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
Marc Veldhoen
2Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
Andreia Gomes
2Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
Marta Serrano
2Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
Catarina Duarte
1Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Center and European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ERN-ReCONNET), Lisbon, Portugal. Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
Maria Rato
3Rheumatology Department, Centro Hospitalar Universitário de São João EPE, Porto, Portugal
Bruno Miguel Fernandes
3Rheumatology Department, Centro Hospitalar Universitário de São João EPE, Porto, Portugal
Salomé Garcia
3Rheumatology Department, Centro Hospitalar Universitário de São João EPE, Porto, Portugal
Filipe Pinheiro
3Rheumatology Department, Centro Hospitalar Universitário de São João EPE, Porto, Portugal
Miguel Bernardes
3Rheumatology Department, Centro Hospitalar Universitário de São João EPE, Porto, Portugal
Nathalie Madeira
4Rheumatology Department, Instituto Português de Reumatologia, Lisbon, Portugal
Cláudia Miguel
4Rheumatology Department, Instituto Português de Reumatologia, Lisbon, Portugal
Rita Torres
5Rheumatology Department, Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal
Ana Bento Silva
5Rheumatology Department, Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal
Jorge Pestana
6Rheumatology Department, Hospital Garcia de Orta, Almada, Portugal
Diogo Almeida
7Rheumatology Department, Hospital de Braga, Braga, Portugal
Carolina Mazeda
8Rheumatology Department, Centro Hospitalar do Baixo Vouga and Ibimed, Institute for Biomedicine, University of Aveiro, Aveiro, Portugal
Filipe Cunha Santos
9Rheumatology Department, Local Health Unit of Guarda, Guarda, Portugal
Patrícia Pinto
10Rheumatology Department, Centro Hospitalar de Vila Nova de Gaia/Espinho, Gaia, Portugal
Marlene Sousa
11Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
Hugo Parente
12Rheumatology Department, Unidade Local de Saúde do Alto Minho, Ponte de Lima, Portugal
Graça Sequeira
13Rheumatology Department, Centro Hospitalar Universitário do Algarve, Faro, Portugal
Maria José Santos
6Rheumatology Department, Hospital Garcia de Orta, Almada, Portugal
João Eurico Fonseca
1Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Center and European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ERN-ReCONNET), Lisbon, Portugal. Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
Vasco C Romão
1Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Center and European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ERN-ReCONNET), Lisbon, Portugal. Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
Data Availability
Data referred to in the manuscript are available upon request to the corresponding author.
Posted October 03, 2021.
Risk factors for infection, predictors of severe disease and antibody response to COVID-19 in patients with rheumatic diseases in Portugal – a multicentre, nationwide study
Ana Rita Cruz-Machado, Sofia C Barreira, Matilde Bandeira, Marc Veldhoen, Andreia Gomes, Marta Serrano, Catarina Duarte, Maria Rato, Bruno Miguel Fernandes, Salomé Garcia, Filipe Pinheiro, Miguel Bernardes, Nathalie Madeira, Cláudia Miguel, Rita Torres, Ana Bento Silva, Jorge Pestana, Diogo Almeida, Carolina Mazeda, Filipe Cunha Santos, Patrícia Pinto, Marlene Sousa, Hugo Parente, Graça Sequeira, Maria José Santos, João Eurico Fonseca, Vasco C Romão
medRxiv 2021.10.01.21264428; doi: https://doi.org/10.1101/2021.10.01.21264428
Risk factors for infection, predictors of severe disease and antibody response to COVID-19 in patients with rheumatic diseases in Portugal – a multicentre, nationwide study
Ana Rita Cruz-Machado, Sofia C Barreira, Matilde Bandeira, Marc Veldhoen, Andreia Gomes, Marta Serrano, Catarina Duarte, Maria Rato, Bruno Miguel Fernandes, Salomé Garcia, Filipe Pinheiro, Miguel Bernardes, Nathalie Madeira, Cláudia Miguel, Rita Torres, Ana Bento Silva, Jorge Pestana, Diogo Almeida, Carolina Mazeda, Filipe Cunha Santos, Patrícia Pinto, Marlene Sousa, Hugo Parente, Graça Sequeira, Maria José Santos, João Eurico Fonseca, Vasco C Romão
medRxiv 2021.10.01.21264428; doi: https://doi.org/10.1101/2021.10.01.21264428
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)